Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Arvaya HealthcareBOM:524723 -1.98%39 PS Ratio is 63.63 as of Aug. 10, 2026, which is 254% above its 10-year median of 17.98. GuruFocus rates BOM:524723 with a GF Score™ of 39/100 and a GF Value™ of ₹50.00 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 118 Medical Distribution companies, Arvaya Healthcare ranks worse than 99.15% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Arvaya Healthcare's share price is ₹119.05.
Arvaya Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹1.87. Hence, Arvaya Healthcare's PS Ratio for today is 63.63.
The historical rank and industry rank for Arvaya Healthcare's PS Ratio or its related term are showing as below:
BOM:524723'
s PS Ratio Range Over the Past 10 Years
Min: 4.54 Med: 17.98 Max: 128.14
Current: 63.63
During the past 13 years, Arvaya Healthcare's highest PS Ratio was 128.14. The lowest was 4.54. And the median was 17.98.
BOM:524723's PS Ratio is ranked worse than 99.15% of 118
companies
in the Medical Distribution industry
Industry Median: 0.395
vs BOM:524723: 63.63
During the past 12 months, the average Revenue per Share Growth Rate of Arvaya Healthcare was 111.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 24.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 3.70% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -6.20% per year.
During the past 13 years, Arvaya Healthcare's highest 3-Year average Revenue per Share Growth Rate was 58.80% per year. The lowest was -27.90% per year. And the median was -3.80% per year.
Arvaya Healthcare (BOM:524723) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Arvaya Healthcare PS Ratio Related Terms
Arvaya Healthcare PS Ratio Historical Data
* Premium members only.
The historical data trend for Arvaya Healthcare's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Arvaya Healthcare's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arvaya Healthcare PS Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Arvaya Healthcare's PS Ratio distribution charts can be found below:
* The bar in red indicates where Arvaya Healthcare's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Arvaya Healthcare's Share Price of today is ₹119.05. Arvaya Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1.87.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Arvaya Healthcare (BOM:524723) has a PS Ratio of 63.63 as of Aug. 10, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Arvaya Healthcare and its competitors. This is 254% above median its historical median of 17.98. Over the past decade, Arvaya Healthcare's PS Ratio has ranged from 4.54 to 128.14. According to the industry distribution chart, Arvaya Healthcare ranks #117 out of 118 companies in the Medical Distribution industry, placing it in the top 99.2%.
Is Arvaya Healthcare's PS Ratio too high?
Arvaya Healthcare's current PS Ratio of 63.63 is 254% above median its 10-year median of 17.98. Over the past 10 years, this metric has ranged from a low of 4.54 to a high of 128.14. The Medical Distribution industry median PS Ratio is 0.40. Arvaya Healthcare's value of 63.63 is 16008.9% above this industry median. Based on the distribution chart, Arvaya Healthcare ranks #117 out of 118 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Arvaya Healthcare has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Arvaya Healthcare's PS Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Arvaya Healthcare ranks #117 out of 118 companies for PS Ratio. This places Arvaya Healthcare in the lower half of its industry. The industry median PS Ratio is 0.40. Arvaya Healthcare's value of 63.63 is 16008.9% above this benchmark. Historically, Arvaya Healthcare's own PS Ratio has ranged from 4.54 to 128.14 over the past decade. While the company's 10-year median is 17.98 vs. the industry median of 0.40, Arvaya Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Distribution company?
The median PS Ratio among Medical Distribution companies is 0.40, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arvaya Healthcare's current PS Ratio of 63.63 is 16008.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Arvaya Healthcare and its competitors. For the Medical Distribution industry, the median PS Ratio is 0.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arvaya Healthcare's current PS Ratio is 63.63, which is 254% above median its own 10-year median of 17.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arvaya Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Arvaya Healthcare (BOM:524723) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹50.00, compared to a current price of ₹119.05 — trading 138.1% above its estimated fair value. The current PS Ratio is 63.63, which is 254% above median its 10-year median of 17.98 and 16008.9% above the Medical Distribution industry median of 0.40. Arvaya Healthcare's overall GF Score™ is 39/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Arvaya Healthcare (BOM:524723), the current PS Ratio is 63.63 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arvaya Healthcare (BOM:524723) Overvalued in 2026?
Based on GuruFocus' analysis, Arvaya Healthcare stock appears to be overvalued.
The current stock price of ₹119.05 is trading 138.1% above its estimated GF Value™ of ₹50.00.
GuruFocus considers Arvaya Healthcare to be Significantly Overvalued.
Key valuation signals for BOM:524723:
PS Ratio: 63.63 (254% above median its 10-year median of 17.98)
GF Value™: ₹50.00 vs. price of ₹119.05 (138.1% above fair value)
Industry Position: 16008.9% above the Medical Distribution median (#117 of 118)
No single metric tells the full story. See the BOM:524723 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arvaya Healthcare Ltd is focused on developing an integrated healthcare platform in India that combines hospital services, diagnostics, wellness services, and digital health management solutions. Its operations include multi-specialty hospitals, a digital health platform for appointment booking and health record management, diagnostic services including laboratory testing and home sample collection, and wellness facilities offering preventive and recovery-focused programs.
39GF Score
Get the complete analysis for BOM:524723
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524723 has been successfully added to your 
